Active Not RecruitingNCT06512389
Evaluating Cannabidiol as a Novel Anticraving Medication for Addiction
Medication studyAges 19+Canada
Understand this study
Who could participate?
Listed age limits: from 19 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 16, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 36
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- Over 19 Years
- Official registry ID
- NCT06512389
- Official title
Show the full official title
Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder: A Human Laboratory Study
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Oral solution.
Who can participate?
Listed age limits: from 19 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
